| |
| |
|
| Insider
Information: |
Ratliff John D |
| Relationship: |
CEO, Covance Drug Deve... |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
16,941 |
|
|
Indirect Shares
|
182,980 |
|
|
| Direct
Value |
$3,405,819 |
|
|
|
Indirect Value
|
$41,540,659 |
|
|
| Total
Shares |
199,921 |
|
|
| Total
Value |
$44,946,478 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
IQVIA Holdings Inc |
IQV |
President and COO |
2013-11-18 |
0 |
2013-11-18 |
182,860 |
Premium* |
|
|
Laboratory Corp of America |
LH |
CEO, Covance Drug Deve... |
2019-04-03 |
16,941 |
2019-04-03 |
120 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2019-04-03 |
4 |
D |
$156.68 |
$169,841 |
D/D |
(1,084) |
16,941 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2019-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,424 |
18,025 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2019-02-12 |
4 |
D |
$146.59 |
$95,870 |
D/D |
(654) |
15,601 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2019-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,463 |
16,255 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2019-02-11 |
4 |
D |
$144.29 |
$284,684 |
D/D |
(1,973) |
14,792 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2019-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,100 |
16,765 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2019-02-07 |
4 |
D |
$147.46 |
$81,988 |
D/D |
(556) |
10,665 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2019-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,863 |
11,261 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2018-02-09 |
4 |
D |
$168.08 |
$358,347 |
D/D |
(2,132) |
9,398 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2018-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,100 |
11,530 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2018-02-07 |
4 |
D |
$169.66 |
$95,010 |
D/D |
(560) |
5,430 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2018-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,863 |
5,990 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2017-02-09 |
4 |
D |
$133.83 |
$269,400 |
D/D |
(2,013) |
4,127 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2017-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,100 |
6,140 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug DevelopmentO |
• – – |
2016-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40 |
|
- |
|
| IQV |
IQVIA Holdings Inc |
President and COO |
• – – |
2013-11-18 |
4 |
S |
$42.55 |
$4,133,307 |
I/I |
(97,140) |
0 |
0 |
- |
|
| IQV |
IQVIA Holdings Inc |
President and COO |
• – – |
2013-11-18 |
4 |
S |
$42.55 |
$4,893,250 |
D/D |
(115,000) |
0 |
0 |
- |
|
| IQV |
IQVIA Holdings Inc |
President and COO |
• – – |
2013-11-18 |
4 |
OE |
$5.76 |
$726,150 |
D/D |
115,000 |
115,000 |
0 |
- |
|
| IQV |
IQVIA Holdings Inc |
President and COOOfficer |
• • – |
2013-05-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
280,000 |
|
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
